BioDelivery Sciences International Inc. Daily Stock Analysis

Daily Stock Analysis, BDSI, BioDelivery Sciences International Inc, priceseries

BioDelivery Sciences International Inc. Daily Stock Analysis
Stock Information
Open
5.59
Close
5.58
High
5.59
Low
5.57
Previous Close
5.59
Daily Price Gain
-0.01
YTD High
5.62
YTD High Date
Feb 28, 2022
YTD Low
2.95
YTD Low Date
Jan 19, 2022
YTD Price Change
2.39
YTD Gain
74.92%
52 Week High
5.62
52 Week High Date
Feb 28, 2022
52 Week Low
2.50
52 Week Low Date
Dec 13, 2021
52 Week Price Change
1.58
52 Week Gain
39.50%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
May 12. 2017
1.90
May 31. 2017
2.24
12 Trading Days
17.97%
Link
LONG
Jun 19. 2017
2.35
Jun 30. 2017
2.66
9 Trading Days
13.16%
Link
LONG
Jul 20. 2017
3.15
Aug 2. 2017
3.32
9 Trading Days
5.52%
Link
LONG
Nov 27. 2017
2.45
Dec 14. 2017
2.66
13 Trading Days
8.43%
Link
LONG
May 16. 2018
1.95
Jun 18. 2018
2.81
22 Trading Days
43.89%
Link
LONG
Sep 28. 2018
2.80
Oct 22. 2018
3.54
16 Trading Days
26.31%
Link
LONG
Dec 28. 2018
3.29
Jan 22. 2019
4.11
15 Trading Days
24.91%
Link
LONG
Aug 8. 2019
4.03
Aug 23. 2019
4.25
11 Trading Days
5.43%
Link
LONG
Oct 3. 2019
4.57
Nov 11. 2019
5.67
27 Trading Days
24.08%
Link
LONG
Mar 26. 2020
3.51
Apr 21. 2020
4.10
17 Trading Days
16.77%
Link
LONG
Aug 5. 2020
4.36
Aug 21. 2020
4.80
12 Trading Days
10.13%
Link
LONG
Dec 4. 2020
4.03
Dec 22. 2020
4.31
12 Trading Days
6.92%
Link
LONG
Jan 20. 2022
3.18
Feb 3. 2022
3.59
10 Trading Days
12.95%
Link
Company Information
Stock Symbol
BDSI
Exchange
NasdaqCM
Company URL
http://www.bdsi.com
Company Phone
919 582 9050
CEO
Mark A. Sirgo
Headquarters
North Carolina
Business Address
4131 PARKLAKE AVENUE, SUITE 225, RALEIGH, NC 27612
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001103021
About

BioDelivery Sciences International, Inc. operates as a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. It focuses on pharmaceutical products in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.

Description

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products principally in the areas of pain management and addiction. The company provides its products based on its patented BioErodible MucoAdhesive (BEMA) drug delivery technology, which consists of a small, erodible polymer film for application to the buccal mucosa. It offers ONSOLIS, a fentanyl buccal soluble film to treat breakthrough pain in opioid patients with cancer; BUNAVAIL, a buprenorphine and naloxone buccal film for the treatment of opioid dependence; and BELBUCA, a buprenorphine buccal film for the treatment of chronic pain. The company also develops Buprenorphine Depot Injection, an injectable microparticle formulation of buprenorphine for the treatment of opioid dependence and chronic pain. It has a licensing and development agreement with Endo Pharmaceuticals, Inc.; Evonik Corporation; Collegium Pharmaceutical, Inc.; and Meda AB. BioDelivery Sciences International, Inc. was founded in 1997 and is headquartered in Raleigh, North Carolina.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading